Embecta EMBC
NASDAQ EMBC
$5.59 +0.29 (+5.47%)
At close: Sep 22, 2026 · 4:00 PM EDT

Embecta (EMBC) Cash & Current Investments (2022 - 2026)

Embecta's (EMBC) quarterly Cash & Current Investments came in at $218.2 million in Q2 2026, down 6.59% year-over-year from $233.6 million in Q2 2025, and up 12.82% quarter-over-quarter from $193.4 million in Q1 2026.

Analysis

Embecta (EMBC) Cash & Current Investments (2022 - 2026) Analysis & Trends

Embecta has disclosed Cash & Current Investments across 5 years of filings, most recently posting $218.2 million for Q2 2026.

  • In Q2 2026, Cash & Current Investments fell 6.59% year-over-year to $218.2 million; the TTM figure through Jun 2026 stood at $218.2 million (down 6.59% YoY), while the FY2025 annual figure was $228.6 million, down 16.63% from the prior year.
  • Cash & Current Investments came in at $218.2 million for Q2 2026 at Embecta, up from $193.4 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $385.2 million in Q4 2022 to a low of $193.4 million in Q1 2026.
  • Average Cash & Current Investments over 5 years is $274.0 million, with a median of $278.0 million recorded in 2024.
  • Year-over-year, Cash & Current Investments soared 31.06% in 2023 and slumped 30.73% in 2025.
  • Over 5 years, Cash & Current Investments stood at $385.2 million in 2022, then slipped by 22.46% to $298.7 million in 2023, then retreated by 27.45% to $216.7 million in 2024, then fell by 5.68% to $204.4 million in 2025, then advanced by 6.75% to $218.2 million in 2026.
  • Per Business Quant data, the three most recent Cash & Current Investments figures were $218.2 million in Q2 2026, $193.4 million in Q1 2026, and $204.4 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Abbott Laboratories 178.18 Bn 173.23 Bn 7.27 Bn 5.60 Bn
2 Intuitive Surgical 142.14 Bn 137.06 Bn 1.96 Bn 5.22 Bn
3 Medtronic 117.43 Bn 109.23 Bn 6.34 Bn 8.82 Bn
4 Stryker 105.15 Bn 101.68 Bn 4.50 Bn 3.48 Bn
5 Boston Scientific 63.37 Bn 63.08 Bn 3.85 Bn 539.00 Mn
6 Edwards Lifesciences 50.93 Bn 46.79 Bn 1.35 Bn 4.25 Bn
7 Dexcom 33.65 Bn 31.71 Bn 830.00 Mn 1.95 Bn
8 Resmed 32.27 Bn 30.80 Bn 861.22 Mn 1.47 Bn
9 Alcon 31.62 Bn 30.17 Bn 1.68 Bn 1.46 Bn
10 Embecta 300.30 Mn 82.10 Mn 153.30 Mn 218.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 218.20 Mn
Mar 31, 2026 193.40 Mn
Dec 31, 2025 204.40 Mn
Sep 30, 2025 228.60 Mn
Jun 30, 2025 233.60 Mn
Mar 31, 2025 212.30 Mn
Dec 31, 2024 216.70 Mn
Sep 30, 2024 274.20 Mn
Jun 30, 2024 281.80 Mn
Mar 31, 2024 306.50 Mn
Dec 31, 2023 298.70 Mn
Sep 30, 2023 326.50 Mn
Jun 30, 2023 317.40 Mn
Mar 31, 2023 346.40 Mn
Dec 31, 2022 385.20 Mn
Sep 30, 2022 330.90 Mn
Jun 30, 2022 292.30 Mn
Mar 31, 2022 264.30 Mn
API Access

Embecta Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=EMBC&period=max&api_key=YOUR_API_KEY